Paola Di Carlo | Medicine and Health Sciences | Best Review Paper Award

Best Review Paper Award

Paola Di Carlo
University of Palermo, Italy

Paola Di Carlo
Affiliation University of Palermo, IT
Country Italy
Scopus ID 6604018676
Documents 147
Citations 2368
h-index 25
Subject Area Medicine and Health Sciences
Event International Environmental Scientists Award
ORCID 0000-0003-4418-5855

Paola Di Carlo is an Italian researcher affiliated with the University of Palermo whose scientific work spans microbiology, infectious diseases, microbiome research, nanomedicine, antimicrobial resistance, and translational medicine. Through a substantial publication record and multidisciplinary collaborations, she has contributed to the advancement of knowledge concerning microbial ecology, cancer-related microbiota, respiratory infections, and innovative therapeutic strategies. Her scholarly profile demonstrates sustained engagement with emerging topics in medicine and health sciences, making her a notable candidate for recognition through the Best Review Paper Award within the International Environmental Scientists Award program.[1]

Abstract

This article reviews the academic profile, publication achievements, and scientific contributions of Paola Di Carlo. Her research portfolio reflects a strong commitment to understanding microbiological processes involved in human disease, including microbiome dysbiosis, antimicrobial resistance, respiratory pathogens, and cancer-associated microbial ecosystems. Recent publications emphasize review-based synthesis of emerging evidence and provide clinically relevant perspectives for researchers and healthcare professionals.[2]

Keywords

Microbiome Research, Antimicrobial Resistance, Infectious Diseases, Nanomedicine, Biliary Cancer, Translational Medicine, Clinical Microbiology, Review Articles, Medical Sciences, Evidence Synthesis.

Introduction

Modern biomedical research increasingly relies on interdisciplinary approaches that integrate microbiology, clinical medicine, molecular biology, and public health. Within this landscape, Paola Di Carlo has developed a research portfolio characterized by scientific rigor and relevance to contemporary healthcare challenges. Her publications explore the relationship between microbial communities and disease progression, while also assessing therapeutic innovations and preventive strategies.[3]

Research Profile

With 147 indexed publications, 2,368 citations, and an h-index of 25, Di Carlo has established a substantial scholarly presence within medicine and health sciences. Her work frequently addresses microbiological determinants of disease, antimicrobial stewardship, pathogen surveillance, and microbiome-mediated mechanisms. The breadth of her research demonstrates both clinical relevance and translational value across multiple healthcare domains.[1]

Research Contributions

  • Investigation of microbiome dysbiosis and its implications for cancer development and therapeutic interventions.
  • Research on multidrug-resistant pathogens and innovative antimicrobial approaches.
  • Evaluation of lipid nanoparticle systems to enhance antibiofilm activity and drug delivery.
  • Clinical studies involving Legionella pneumophila infections and epidemiological assessment.
  • Comprehensive review articles synthesizing current evidence on biliary and pancreatic tract diseases.

Publications

  • Polyphenols and ADPKD: A Further Aid from Nature? Life (2026).
  • Biliary Tract and Pancreatic Cancer (BTPC) in Adult Patients: The Role of the Biliary Microbiota in Cancer and Therapeutic Strategies—A Scoping Review. Cancers (2026).
  • Multicomponent Lipid Nanoparticles as a Tool to Potentially Improve the Antibiofilm Activity of Resveratrol against MDR Clinical Isolates. ACS Omega (2026).
  • Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases.
  • Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens (2025).

Research Impact

The impact of Di Carlo’s research is reflected through consistent citation activity, interdisciplinary collaborations, and publication in internationally recognized journals. Her review articles provide valuable syntheses of emerging evidence, enabling clinicians and researchers to better understand disease mechanisms and potential treatment pathways. Such contributions support evidence-based healthcare decision-making and stimulate future research initiatives.[4]

Award Suitability

Paola Di Carlo demonstrates qualities commonly associated with recipients of review-focused academic distinctions. Her ability to consolidate complex scientific evidence, identify knowledge gaps, and communicate research findings in accessible scholarly formats contributes significantly to the advancement of medicine and health sciences. The depth and relevance of her recent review publications align strongly with the objectives of the Best Review Paper Award.[5]

Conclusion

Paola Di Carlo has developed a distinguished academic record characterized by productive scholarship, interdisciplinary engagement, and meaningful contributions to microbiology and medical research. Her publication portfolio, citation impact, and emphasis on comprehensive review-based scholarship provide a strong foundation for recognition within international scientific award programs. The available evidence supports her suitability for acknowledgment through the Best Review Paper Award.

References

  1. Elsevier. (n.d.). Scopus author details: Paola Di Carlo, Author ID 6604018676. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6604018676
  2. Di Carlo, P. et al. (2026). Polyphenols and ADPKD: A Further Aid from Nature? Life.
    https://doi.org/10.3390/life16061022
  3. Di Carlo, P. et al. (2026). Biliary Tract and Pancreatic Cancer in Adult Patients: A Scoping Review. Cancers.
    https://doi.org/10.3390/cancers18121875
  4. Di Carlo, P. et al. (2026). Multicomponent Lipid Nanoparticles and Antibiofilm Activity. ACS Omega.
    https://doi.org/10.1021/acsomega.5c12649
  5. Di Carlo, P. (2026). Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases. OSF.
    https://doi.org/10.17605/osf.io/uc34p
  6. Di Carlo, P. et al. (2025). Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens.
    https://doi.org/10.3390/pathogens15010013

George Vaos | Medicine | Stellar Contributions to Science Award

Prof. Dr. George Vaos | Medicine | Stellar Contributions to Science Award

Prof. Dr. George Vaos | Medicine | National and Kapodistrian University of Athens | Greece

Prof. Dr. George Vaos is an internationally recognized male academic and clinician whose scholarly and professional contributions have significantly advanced pediatric surgery and its intersections with public health, clinical epidemiology, and evidence-based medical science. His educational background includes comprehensive medical training followed by advanced doctoral-level education at a prestigious European university, where he developed a strong foundation in surgical sciences, clinical research methodology, and translational medicine, later complemented by continuous academic development within leading medical institutions.

Citation Metrics (Google Scholar)

2500

2000

1500

1000

500

0

.

Citations
1817
i10index
43

h-index
24

                  🟦 Citations      🟥 i10index          🟩 h-index

View Google Scholar Profile

Featured Publications:

Multicenter Assessment of Ultrasound of the Spermatic Cord in Children with Acute Scrotum

– The Journal of Urology, 2007 · 254 Citations
Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic Review

– Digestive Diseases and Sciences, 2013 · 113 Citations
The Role of Calprotectin in Pediatric Disease

– BioMed Research International, 2013 · 108 Citations
Optimal Timing for Repair of an Inguinal Hernia in Premature Infants

– Pediatric Surgery International, 2010 · 88 Citations
Immediate Surgery or Conservative Treatment for Complicated Acute Appendicitis in Children? A Meta-Analysis

– Journal of Pediatric Surgery, 2019 · 81 Citations

 

Dr. Carlos Roldan | Medicine | Best Researcher Award

Dr. Carlos Roldan | Medicine | Best Researcher Award

Hossein Azizi Nadian is a dedicated researcher and academic in the field of Civil, Environmental, and Architectural Engineering, with a keen focus on water supply networks and hydraulic systems. Currently pursuing his Ph.D. at Università degli Studi di Brescia, Italy, Hossein’s work is recognized for its innovative approach to leak detection and network digitization.

Profile 📝

Scopus

Carlos Roldan, MD, FAAEM, FACEP is a strong candidate for the “Best Researcher Award” based on several key strengths and a few areas for improvement. Here’s a detailed assessment:

Strengths 💪

Extensive Academic and Clinical Experience: Dr. Roldan has a robust academic background, holding multiple positions in esteemed institutions such as The University of Texas MD Anderson Cancer Center and McGovern Medical School. His experience spans both emergency medicine and pain management, demonstrating his versatility and broad expertise.

Diverse Research Contributions: He has contributed to a wide array of research topics, particularly in pain management, emergency medicine, and innovative treatment methodologies. His work on methylene blue for oral mucositis, myofascial pain syndromes, and the impact of micronutrient deficiencies on chronic pain showcases his ability to address complex and varied clinical challenges.

Publication Record: Dr. Roldan has a substantial number of peer-reviewed publications, including articles in high-impact journals. This indicates not only a high level of productivity but also recognition by the scientific community.

Research Leadership and Grants: He has successfully led several research studies as a Principal Investigator, securing internal funding and managing significant research projects. His involvement in a diverse range of clinical trials and studies highlights his leadership and ability to drive research forward.

Recognition and Awards: Dr. Roldan has received multiple honors, such as the Excellence in Teaching Award and the Dean’s Teaching Excellence Award, reflecting his contributions to education and research.

Innovation and Patents: His patent on methylene blue solution for oral lesions illustrates his innovative approach and potential impact on clinical practice.

Areas for Improvement 🔧

Broader Impact Metrics: While Dr. Roldan’s research is extensive, focusing on increasing the broader impact of his work, such as community outreach or policy changes, could further enhance his candidacy. Demonstrating how his research has influenced clinical practice or patient outcomes could strengthen his application.

Interdisciplinary Collaboration: Although he has a diverse research portfolio, increasing interdisciplinary collaborations could provide new insights and enhance the applicability of his research findings. Partnering with researchers from other fields could lead to novel approaches and greater innovation.

Update on Non-Funded Research: Several of Dr. Roldan’s ongoing projects are listed as non-funded or in data collection stages. Demonstrating progress or preliminary findings from these studies could provide a more current view of his research impact.

Research Dissemination and Translation: Highlighting how his research findings have been translated into practice or have influenced clinical guidelines would further showcase the practical impact of his work. Emphasizing efforts to disseminate research results beyond academic publications could be beneficial.

Education 🎓

Hossein holds a Master’s degree in Civil Engineering from Khorramshahr University, Iran, where his research on wastewater jet diffusion in stagnant waters laid the groundwork for his future studies. His academic journey continues with a Ph.D. at Università degli Studi di Brescia, where he delves into advanced topics in engineering and mathematics.

Experience 🏆

Hossein has made significant contributions to both academic and professional fields through multiple collaborations and organizational roles. His experience spans river engineering, eco-hydraulics, and hydraulic modeling, with a particular emphasis on applying digital technologies to improve water supply networks.

Research Interests 🔍

Hossein’s research interests include digitization and leak detection in water supply networks, river engineering, eco-hydraulics, and hydraulic modeling. He is particularly focused on how innovative technologies can be leveraged to improve the sustainability and efficiency of hydraulic systems.

Awards 🏅

Hossein has been recognized for his excellence in research, including being nominated for various awards. His participation in international conferences has also earned him accolades for his contributions to the field of civil engineering.

Publication Top Notes 📚

Methylene Blue, a Unique Topical Analgesic: A Case Report

Diagnostic and therapeutic value of intracellular biomarker testing in chronic pain

Temporal characterization of acute pain and toxicity kinetics during radiation therapy for head and neck cancer. A retrospective study

Methylene blue for the treatment of oral mucositis associated with cancer treatment in a pediatric patient

Methylene Blue for the Treatment of Radiation-Induced Oral Mucositis during Head and Neck Cancer Treatment: An Uncontrolled Cohort

Genicular nerve neurolysis with phenol for chronic knee pain: A case series

Ultrasound-guided superficial cervical plexus block for cancer-related clavicle pain

Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial

Non-Invasive Pelvic Floor Rehabilitation in Cancer Population: An Incomplete Cohort

Subanesthetic ketamine in the ambulatory setting for refractory cancer pain: A 6-year retrospective at a cancer center

Conclusion 🎯

Dr. Carlos Roldan is highly suitable for the “Best Researcher Award” due to his extensive research experience, impactful contributions, and recognition in his field. To strengthen his application, he could focus on demonstrating the broader impact of his research, increasing interdisciplinary collaborations, updating on current non-funded projects, and emphasizing the translation of research findings into clinical practice. His impressive track record and innovative contributions make him a strong candidate for this prestigious award.